Auris Medical Resumes Enrollment in TACTT3 Phase 3 Trial of Keyzilen in Acute and Post-Acute Tinnitus Biotech Investing
Laguna Completes Definitive Equity Agreement with Carlsbad Naturals for Nano-Amplified CBD Water Biotech Investing
Medtronic Announces Medicare Coverage Decision for the First and Only Leadless Pacemaker Available for Use in the U.S. Medical Device Investing
Pediapharm Announces the Commercial Launch of Rupall(TM) (Rupatadine) in Canada Pharmaceutical Investing
BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s Macroglobulinemia Biotech Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
